Elanco Animal Health Return on Tangible Equity 2016-2026 | ELAN
Current and historical return on tangible equity values for Elanco Animal Health (ELAN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Elanco Animal Health Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2026-06-30 | $-0.20B | $-1.54B | 12.92% |
| 2026-03-31 | $-0.24B | $-1.60B | 15.16% |
| 2025-12-31 | $-0.23B | $-1.68B | 13.79% |
| 2025-09-30 | $0.04B | $-1.77B | -2.03% |
| 2025-06-30 | $0.43B | $-1.90B | -22.88% |
| 2025-03-31 | $0.37B | $-2.11B | -17.68% |
| 2024-12-31 | $0.34B | $-2.32B | -14.59% |
| 2024-09-30 | $0.21B | $-2.66B | -7.71% |
| 2024-06-30 | $-1.26B | $-2.94B | 42.67% |
| 2024-03-31 | $-1.30B | $-3.13B | 41.58% |
| 2023-12-31 | $-1.23B | $-3.32B | 37.08% |
| 2023-09-30 | $-1.14B | $-3.37B | 34.00% |
| 2023-06-30 | $-0.11B | $-3.49B | 3.24% |
| 2023-03-31 | $-0.03B | $-3.62B | 0.72% |
| 2022-12-31 | $-0.08B | $-3.75B | 2.08% |
| 2022-09-30 | $-0.13B | $-3.93B | 3.36% |
| 2022-06-30 | $-0.17B | $-4.07B | 4.20% |
| 2022-03-31 | $-0.37B | $-4.12B | 9.00% |
| 2021-12-31 | $-0.48B | $-4.16B | 11.62% |
| 2021-09-30 | $-0.71B | $-4.13B | 17.24% |
| 2021-06-30 | $-0.74B | $-4.02B | 18.50% |
| 2021-03-31 | $-0.59B | $-2.72B | 21.55% |
| 2020-12-31 | $-0.57B | $-1.41B | 40.75% |
| 2020-09-30 | $-0.25B | $-0.36B | 69.05% |
| 2020-06-30 | $-0.10B | $0.64B | -15.80% |
| 2020-03-31 | $-0.01B | $0.33B | -3.60% |
| 2019-12-31 | $0.07B | $0.00B | 2760.00% |
| 2019-09-30 | $0.09B | $-0.08B | -114.29% |
| 2019-06-30 | $0.14B | $-0.20B | -73.66% |
| 2019-03-31 | $0.05B | $-0.18B | -24.49% |
| 2018-12-31 | $0.09B | $-0.15B | -56.21% |
| 2018-06-30 | $-0.01B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $11.421B | $4.715B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.874B | 13.39 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.368B | 15.15 |
| Encompass Health (EHC) | United States | $12.224B | 21.22 |
| Chemed (CHE) | United States | $6.665B | 23.76 |
| RadNet (RDNT) | United States | $5.964B | 172.23 |
| LifeStance Health (LFST) | United States | $4.888B | 98.39 |
| Option Care Health (OPCH) | United States | $3.665B | 15.49 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.112B | 21.61 |
| Addus HomeCare (ADUS) | United States | $2.213B | 20.02 |
| Astrana Health (ASTH) | United States | $2.101B | 22.31 |
| Pennant (PNTG) | United States | $1.484B | 38.62 |
| U.S Physical Therapy (USPH) | United States | $1.244B | 32.83 |
| Daxor (DXR) | United States | $0.068B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.022B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |